A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.
Session Topics:
2024 Showcase Finalist
Milestone - Bridge Funding
Funding
Family Office
Companion and Livestock
Biopharma
Seed
Prevention
Treatment
Speaker(s):
Asel Sartbaeva
CEO
EnsiliTech
Time:
1.05pm - 1.25pm
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)